Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

about

Cardiovascular effects of anti-diabetes drugs.Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.

P2860

Q38857056-9CC6AD42-D2B6-4BC2-A63F-B349E7D3E96D Q48022106-A6E265C7-6517-4893-930D-9BE14A92FA42

P2860

Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q40844288

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Effects of sulfonylureas on li ...... randomized controlled trials.

@en

type

Item

label

Effects of sulfonylureas on li ...... randomized controlled trials.

@en

prefLabel

Effects of sulfonylureas on li ...... randomized controlled trials.

@en

P1476

Effects of sulfonylureas on li ...... randomized controlled trials.

@en

P2093

Guan-jian Liu

http://www.w3.org/2001/XMLSchema#string

Jia-ni Shen

http://www.w3.org/2001/XMLSchema#string

Liang Du

http://www.w3.org/2001/XMLSchema#string

Xin Sun

http://www.w3.org/2001/XMLSchema#string

Xing-yuan Geng

http://www.w3.org/2001/XMLSchema#string

Yong-gang Zhang

http://www.w3.org/2001/XMLSchema#string

Yuan-ling Peng

http://www.w3.org/2001/XMLSchema#string

Yue-hong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatic beta-cells.

Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose

Progress and challenges in translating the biology of atherosclerosis

Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes.

Randomized controlled trial of single-agent glimepiride and pioglitazone in Japanese patients with type 2 diabetes: A comparative study.

The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data.

Lipid metabolism as a target for potassium channel effectors.

Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.

P304

134-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/JEBM.12157

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26066789

http://www.w3.org/2001/XMLSchema#string

Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

about

P2860

P2860

Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698